Sodium channel protein type 2 subunit alpha (Nav1.2)

The Sodium channel protein type 2 subunit alpha (Nav1.2), encoded by the SCN2A gene, is a critical voltage-gated sodium channel primarily expressed in the central nervous system, particularly within the axon initial segment of excitatory neurons. It plays a fundamental role in the initiation and propagation of action potentials, thereby regulating neuronal excitability and synaptic transmission throughout development (UniProt P35498). While the channel typically produces a transient current that rapidly inactivates, certain pathological conditions or gain-of-function mutations result in an increased persistent current—a sustained sodium influx that fails to inactivate (Sanders et al., 2018). This persistent current leads to membrane depolarization and repetitive firing, which is a hallmark of various forms of early-onset epilepsy and neurodevelopmental disorders (Wolff et al., 2017). Therapeutic strategies often involve the use of sodium channel blockers that stabilize the channel's inactivated state or specifically target the persistent current to restore normal electrical activity (Ben-Shalom et al., 2017). Understanding the balance between transient and persistent currents in Nav1.2 is essential for developing precision medicines for SCN2A-related encephalopathies and autism spectrum disorders.

Other names

SCN2ASodium channel voltage-gated type II alpha subunitHBSC IINAC2Voltage-gated sodium channel subunit alpha Nav1.2

Voltage-gated sodium channel blockers stabilize the channel in its inactivated state, thereby reducing the frequency of neuronal firing. Specifically, certain therapeutic agents are designed to preferentially inhibit the persistent sodium current (INaP)—a non-inactivating component of the sodium flux—over the transient current to suppress pathological hyperexcitability while sparing normal physiological signaling.